Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM) Meeting Abstract
| Authors: | Ikeguchi, A.; Sato, T.; Butler, M. O.; Carvajal, R. D.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Nathan, P. D.; Piulats, J. M.; Johnson, D. B.; Luke, J. J.; Espinosa, E.; Leyvraz, S.; Collins, L.; Edukulla, R.; Thiyagarajah, P.; Hamid, O. |
| Abstract Title: | Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402219 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.9529 |
| Notes: | Meeting Abstract: 9529 -- Source: Wos |
